nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—RET—enteric nervous system—narcolepsy	0.118	0.165	CbGeAlD
Sorafenib—RET—autonomic nervous system—narcolepsy	0.0414	0.058	CbGeAlD
Sorafenib—CDKL2—forebrain—narcolepsy	0.0318	0.0446	CbGeAlD
Sorafenib—MAPK15—brainstem—narcolepsy	0.0297	0.0416	CbGeAlD
Sorafenib—MAPK15—medulla oblongata—narcolepsy	0.0207	0.029	CbGeAlD
Sorafenib—CDKL3—brain—narcolepsy	0.0144	0.0202	CbGeAlD
Sorafenib—CDKL2—brain—narcolepsy	0.0132	0.0185	CbGeAlD
Sorafenib—MAPK15—brain—narcolepsy	0.0119	0.0167	CbGeAlD
Sorafenib—RALBP1—forebrain—narcolepsy	0.00893	0.0125	CbGeAlD
Sorafenib—RAF1—brainstem—narcolepsy	0.00875	0.0123	CbGeAlD
Sorafenib—RAF1—forebrain—narcolepsy	0.00844	0.0118	CbGeAlD
Sorafenib—EPHB6—forebrain—narcolepsy	0.00839	0.0118	CbGeAlD
Sorafenib—BRAF—midbrain—narcolepsy	0.00837	0.0117	CbGeAlD
Sorafenib—HIPK4—brain—narcolepsy	0.008	0.0112	CbGeAlD
Sorafenib—PDGFRA—forebrain—narcolepsy	0.00796	0.0112	CbGeAlD
Sorafenib—FGFR1—medulla oblongata—narcolepsy	0.00778	0.0109	CbGeAlD
Sorafenib—MAP2K5—brainstem—narcolepsy	0.00744	0.0104	CbGeAlD
Sorafenib—MAP3K7—medulla oblongata—narcolepsy	0.00737	0.0103	CbGeAlD
Sorafenib—KDR—forebrain—narcolepsy	0.00718	0.0101	CbGeAlD
Sorafenib—MKNK2—medulla oblongata—narcolepsy	0.00714	0.01	CbGeAlD
Sorafenib—FGFR1—midbrain—narcolepsy	0.00712	0.00997	CbGeAlD
Sorafenib—MKNK1—medulla oblongata—narcolepsy	0.00705	0.00988	CbGeAlD
Sorafenib—MAPK11—brain—narcolepsy	0.00705	0.00988	CbGeAlD
Sorafenib—CSF1R—forebrain—narcolepsy	0.00701	0.00982	CbGeAlD
Sorafenib—RET—medulla oblongata—narcolepsy	0.00697	0.00976	CbGeAlD
Sorafenib—CDK7—brain—narcolepsy	0.00694	0.00972	CbGeAlD
Sorafenib—TAOK2—brain—narcolepsy	0.00688	0.00965	CbGeAlD
Sorafenib—AURKC—brain—narcolepsy	0.00683	0.00957	CbGeAlD
Sorafenib—MAP3K7—midbrain—narcolepsy	0.00674	0.00944	CbGeAlD
Sorafenib—KIT—brainstem—narcolepsy	0.00659	0.00924	CbGeAlD
Sorafenib—MKNK2—midbrain—narcolepsy	0.00653	0.00915	CbGeAlD
Sorafenib—RALBP1—medulla oblongata—narcolepsy	0.00645	0.00904	CbGeAlD
Sorafenib—MKNK1—midbrain—narcolepsy	0.00645	0.00903	CbGeAlD
Sorafenib—RET—midbrain—narcolepsy	0.00637	0.00892	CbGeAlD
Sorafenib—EPHA6—brain—narcolepsy	0.00633	0.00887	CbGeAlD
Sorafenib—FLT1—medulla oblongata—narcolepsy	0.00614	0.0086	CbGeAlD
Sorafenib—RAF1—medulla oblongata—narcolepsy	0.0061	0.00855	CbGeAlD
Sorafenib—EPHB6—medulla oblongata—narcolepsy	0.00606	0.0085	CbGeAlD
Sorafenib—ZAK—brain—narcolepsy	0.006	0.0084	CbGeAlD
Sorafenib—RALBP1—midbrain—narcolepsy	0.0059	0.00826	CbGeAlD
Sorafenib—HIPK3—brain—narcolepsy	0.00587	0.00822	CbGeAlD
Sorafenib—MAP3K19—brain—narcolepsy	0.00575	0.00806	CbGeAlD
Sorafenib—FLT1—midbrain—narcolepsy	0.00561	0.00786	CbGeAlD
Sorafenib—RAF1—midbrain—narcolepsy	0.00558	0.00781	CbGeAlD
Sorafenib—EPHB6—midbrain—narcolepsy	0.00554	0.00777	CbGeAlD
Sorafenib—TIE1—brain—narcolepsy	0.00548	0.00769	CbGeAlD
Sorafenib—HTR2C—brainstem—narcolepsy	0.00543	0.00761	CbGeAlD
Sorafenib—BRAF—brain—narcolepsy	0.00526	0.00737	CbGeAlD
Sorafenib—HTR2C—forebrain—narcolepsy	0.00524	0.00734	CbGeAlD
Sorafenib—MAP2K5—medulla oblongata—narcolepsy	0.00519	0.00727	CbGeAlD
Sorafenib—KDR—medulla oblongata—narcolepsy	0.00519	0.00727	CbGeAlD
Sorafenib—CSF1R—medulla oblongata—narcolepsy	0.00506	0.00709	CbGeAlD
Sorafenib—EPHX2—brain—narcolepsy	0.00503	0.00704	CbGeAlD
Sorafenib—ABCC4—forebrain—narcolepsy	0.00495	0.00693	CbGeAlD
Sorafenib—HTR2B—forebrain—narcolepsy	0.00492	0.0069	CbGeAlD
Sorafenib—KDR—midbrain—narcolepsy	0.00474	0.00664	CbGeAlD
Sorafenib—MAP2K5—midbrain—narcolepsy	0.00474	0.00664	CbGeAlD
Sorafenib—CSF1R—midbrain—narcolepsy	0.00463	0.00648	CbGeAlD
Sorafenib—KIT—medulla oblongata—narcolepsy	0.0046	0.00644	CbGeAlD
Sorafenib—FLT4—brain—narcolepsy	0.00453	0.00635	CbGeAlD
Sorafenib—PDGFRB—medulla oblongata—narcolepsy	0.00449	0.00629	CbGeAlD
Sorafenib—FGFR1—brain—narcolepsy	0.00447	0.00627	CbGeAlD
Sorafenib—MAP3K7—brain—narcolepsy	0.00423	0.00593	CbGeAlD
Sorafenib—KIT—midbrain—narcolepsy	0.0042	0.00589	CbGeAlD
Sorafenib—PDGFRB—midbrain—narcolepsy	0.0041	0.00575	CbGeAlD
Sorafenib—MKNK2—brain—narcolepsy	0.0041	0.00575	CbGeAlD
Sorafenib—MKNK1—brain—narcolepsy	0.00405	0.00568	CbGeAlD
Sorafenib—RET—brain—narcolepsy	0.004	0.00561	CbGeAlD
Sorafenib—HTR2C—medulla oblongata—narcolepsy	0.00378	0.0053	CbGeAlD
Sorafenib—RALBP1—brain—narcolepsy	0.0037	0.00519	CbGeAlD
Sorafenib—FLT1—brain—narcolepsy	0.00352	0.00494	CbGeAlD
Sorafenib—RAF1—brain—narcolepsy	0.0035	0.00491	CbGeAlD
Sorafenib—EPHB6—brain—narcolepsy	0.00348	0.00488	CbGeAlD
Sorafenib—HTR2C—midbrain—narcolepsy	0.00346	0.00485	CbGeAlD
Sorafenib—STK10—brain—narcolepsy	0.00334	0.00467	CbGeAlD
Sorafenib—PDGFRA—brain—narcolepsy	0.0033	0.00463	CbGeAlD
Sorafenib—MAP2K5—brain—narcolepsy	0.00298	0.00417	CbGeAlD
Sorafenib—KDR—brain—narcolepsy	0.00298	0.00417	CbGeAlD
Sorafenib—CSF1R—brain—narcolepsy	0.00291	0.00407	CbGeAlD
Sorafenib—KIT—brain—narcolepsy	0.00264	0.0037	CbGeAlD
Sorafenib—PDGFRB—brain—narcolepsy	0.00258	0.00361	CbGeAlD
Sorafenib—ABCG2—medulla oblongata—narcolepsy	0.00252	0.00354	CbGeAlD
Sorafenib—CYP2D6—brainstem—narcolepsy	0.00248	0.00348	CbGeAlD
Sorafenib—CYP2D6—forebrain—narcolepsy	0.00239	0.00336	CbGeAlD
Sorafenib—ABCG2—midbrain—narcolepsy	0.00231	0.00323	CbGeAlD
Sorafenib—HTR2C—brain—narcolepsy	0.00217	0.00305	CbGeAlD
Sorafenib—ABCC4—brain—narcolepsy	0.00205	0.00288	CbGeAlD
Sorafenib—HTR2B—brain—narcolepsy	0.00204	0.00286	CbGeAlD
Sorafenib—ABCB1—forebrain—narcolepsy	0.00172	0.00241	CbGeAlD
Sorafenib—CYP2C8—brain—narcolepsy	0.00149	0.00209	CbGeAlD
Sorafenib—ABCG2—brain—narcolepsy	0.00145	0.00203	CbGeAlD
Sorafenib—CYP2B6—brain—narcolepsy	0.00134	0.00187	CbGeAlD
Sorafenib—ABCB1—medulla oblongata—narcolepsy	0.00124	0.00174	CbGeAlD
Sorafenib—ABCB1—midbrain—narcolepsy	0.00114	0.00159	CbGeAlD
Sorafenib—CYP2D6—brain—narcolepsy	0.000993	0.00139	CbGeAlD
Sorafenib—ABCB1—brain—narcolepsy	0.000715	0.001	CbGeAlD
Sorafenib—MAPK11—Signaling Pathways—P2RY11—narcolepsy	0.000365	0.00128	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CHKB—narcolepsy	0.000362	0.00126	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CHKB—narcolepsy	0.000362	0.00126	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—P2RY11—narcolepsy	0.000362	0.00126	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HCRT—narcolepsy	0.000361	0.00126	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—HRH3—narcolepsy	0.000361	0.00126	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HCRT—narcolepsy	0.00036	0.00126	CbGpPWpGaD
Sorafenib—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000356	0.00124	CbGpPWpGaD
Sorafenib—RAF1—TNF alpha Signaling Pathway—TNF—narcolepsy	0.00035	0.00122	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000348	0.00122	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.000344	0.0012	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.000343	0.0012	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HCRTR1—narcolepsy	0.000341	0.00119	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HCRTR1—narcolepsy	0.000341	0.00119	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HCRTR2—narcolepsy	0.000341	0.00119	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HCRTR2—narcolepsy	0.000341	0.00119	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.000334	0.00117	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.000334	0.00117	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—NPS—narcolepsy	0.000332	0.00116	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TAC1—narcolepsy	0.000332	0.00116	CbGpPWpGaD
Sorafenib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000331	0.00116	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—PENK—narcolepsy	0.00033	0.00115	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—P2RY11—narcolepsy	0.000329	0.00115	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—P2RY11—narcolepsy	0.000329	0.00115	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000327	0.00114	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HCRTR2—narcolepsy	0.000324	0.00113	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HCRTR1—narcolepsy	0.000324	0.00113	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HCRTR2—narcolepsy	0.000323	0.00113	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HCRTR1—narcolepsy	0.000323	0.00113	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PENK—narcolepsy	0.000322	0.00112	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.000322	0.00112	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—PENK—narcolepsy	0.000321	0.00112	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—P2RY11—narcolepsy	0.000313	0.00109	CbGpPWpGaD
Sorafenib—BRAF—MAPK Signaling Pathway—TNF—narcolepsy	0.000312	0.00109	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—P2RY11—narcolepsy	0.000312	0.00109	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.000311	0.00109	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HCRT—narcolepsy	0.000311	0.00108	CbGpPWpGaD
Sorafenib—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000308	0.00107	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HCRT—narcolepsy	0.000308	0.00107	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CHKB—narcolepsy	0.000307	0.00107	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000305	0.00107	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CHKB—narcolepsy	0.000304	0.00106	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000304	0.00106	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000303	0.00106	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000303	0.00106	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—NPS—narcolepsy	0.000299	0.00104	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TAC1—narcolepsy	0.000299	0.00104	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000298	0.00104	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.000292	0.00102	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000291	0.00102	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HCRTR1—narcolepsy	0.000291	0.00102	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HCRTR2—narcolepsy	0.000291	0.00102	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000287	0.001	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000287	0.001	CbGpPWpGaD
Sorafenib—MAP3K7—MAPK Signaling Pathway—TNF—narcolepsy	0.000284	0.000993	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000283	0.000988	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000283	0.000988	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.000282	0.000985	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—P2RY11—narcolepsy	0.000281	0.000981	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TRH—narcolepsy	0.000281	0.000981	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HCRT—narcolepsy	0.00028	0.000978	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HCRT—narcolepsy	0.00028	0.000978	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.000277	0.000968	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.000277	0.000968	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.000277	0.000968	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PENK—narcolepsy	0.000277	0.000967	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PENK—narcolepsy	0.000274	0.000957	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TRH—narcolepsy	0.000274	0.000956	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—TRH—narcolepsy	0.000273	0.000953	CbGpPWpGaD
Sorafenib—FGFR1—MAPK Signaling Pathway—TNF—narcolepsy	0.00027	0.000942	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000269	0.000938	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000268	0.000935	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.000268	0.000935	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HCRT—narcolepsy	0.000266	0.000928	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HCRT—narcolepsy	0.000265	0.000926	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000264	0.000921	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00026	0.000907	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.00026	0.000906	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HCRTR1—narcolepsy	0.000259	0.000905	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HCRTR2—narcolepsy	0.000259	0.000905	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000258	0.000901	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.000256	0.000895	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—TNF—narcolepsy	0.000253	0.000884	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—P2RY11—narcolepsy	0.00025	0.000874	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PENK—narcolepsy	0.00025	0.000872	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PENK—narcolepsy	0.00025	0.000872	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.000249	0.000869	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—HRH3—narcolepsy	0.000246	0.00086	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CPT1B—narcolepsy	0.000246	0.000859	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CPT1B—narcolepsy	0.000246	0.000859	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—HTR2A—narcolepsy	0.000245	0.000855	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000244	0.00085	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000243	0.000848	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TNF—narcolepsy	0.000243	0.000846	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000241	0.000843	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—HTR2A—narcolepsy	0.000241	0.000842	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HRH3—narcolepsy	0.00024	0.000838	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HRH3—narcolepsy	0.00024	0.000836	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HCRT—narcolepsy	0.000239	0.000834	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TNF—narcolepsy	0.000238	0.000831	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PENK—narcolepsy	0.000237	0.000827	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000237	0.000827	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PENK—narcolepsy	0.000236	0.000825	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000236	0.000823	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TRH—narcolepsy	0.000235	0.000822	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.000234	0.000816	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.000234	0.000816	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TRH—narcolepsy	0.000233	0.000814	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00023	0.000803	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000229	0.000801	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000229	0.000801	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.000228	0.000795	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.000228	0.000795	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CHKB—narcolepsy	0.000225	0.000786	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	0.000224	0.000781	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	0.000224	0.000781	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CHKB—narcolepsy	0.00022	0.000768	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—P2RY11—narcolepsy	0.000216	0.000755	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TNF—narcolepsy	0.000216	0.000754	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000215	0.000751	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000215	0.000751	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000215	0.000751	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PENK—narcolepsy	0.000213	0.000743	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HCRT—narcolepsy	0.000213	0.000743	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—TAC1—narcolepsy	0.000212	0.000741	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—NPS—narcolepsy	0.000212	0.000741	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TRH—narcolepsy	0.000212	0.000741	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TRH—narcolepsy	0.000212	0.000741	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CPT1B—narcolepsy	0.000209	0.000729	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CPT1B—narcolepsy	0.000207	0.000722	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HRH3—narcolepsy	0.000207	0.000722	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HRH3—narcolepsy	0.000206	0.000721	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HRH3—narcolepsy	0.000205	0.000714	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000204	0.000713	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TAC1—narcolepsy	0.000204	0.000713	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—NPS—narcolepsy	0.000204	0.000713	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000204	0.000711	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DQA1—narcolepsy	0.000204	0.000711	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PENK—narcolepsy	0.000203	0.000709	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000202	0.000706	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TRH—narcolepsy	0.000201	0.000703	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TRH—narcolepsy	0.000201	0.000701	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	0.000201	0.000701	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—HTR2A—narcolepsy	0.0002	0.000697	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TAC1—narcolepsy	0.000199	0.000694	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—NPS—narcolepsy	0.000199	0.000694	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—TAC1—narcolepsy	0.000198	0.000693	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—NPS—narcolepsy	0.000198	0.000693	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000195	0.000681	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CHKB—narcolepsy	0.000191	0.000665	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DQB1—narcolepsy	0.00019	0.000665	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PENK—narcolepsy	0.00019	0.000662	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	0.000189	0.000659	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—NPS—narcolepsy	0.000189	0.000659	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000186	0.000651	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HRH3—narcolepsy	0.000186	0.00065	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HRH3—narcolepsy	0.000186	0.00065	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HCRT—narcolepsy	0.000184	0.000642	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DQA1—narcolepsy	0.000184	0.000641	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DQA1—narcolepsy	0.000184	0.000641	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000184	0.000641	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TRH—narcolepsy	0.000181	0.000632	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—HTR2A—narcolepsy	0.00018	0.000628	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HRH3—narcolepsy	0.000177	0.000617	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HRH3—narcolepsy	0.000176	0.000615	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DQA1—narcolepsy	0.000174	0.000608	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DQA1—narcolepsy	0.000174	0.000607	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TRH—narcolepsy	0.000173	0.000603	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DQB1—narcolepsy	0.000172	0.000599	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DQB1—narcolepsy	0.000172	0.000599	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—TAC1—narcolepsy	0.000171	0.000598	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—NPS—narcolepsy	0.000171	0.000598	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TAC1—narcolepsy	0.000171	0.000597	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NPS—narcolepsy	0.000171	0.000597	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CHKB—narcolepsy	0.00017	0.000594	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TAC1—narcolepsy	0.000169	0.000592	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NPS—narcolepsy	0.000169	0.000592	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CHKB—narcolepsy	0.000166	0.00058	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PENK—narcolepsy	0.000164	0.000572	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000164	0.000571	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DQB1—narcolepsy	0.000163	0.000569	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DQB1—narcolepsy	0.000163	0.000567	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TRH—narcolepsy	0.000161	0.000563	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HRH3—narcolepsy	0.000159	0.000554	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DQA1—narcolepsy	0.000157	0.000547	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CHKB—narcolepsy	0.000157	0.000546	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CHKB—narcolepsy	0.000155	0.000542	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TNF—narcolepsy	0.000155	0.00054	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TAC1—narcolepsy	0.000154	0.000538	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NPS—narcolepsy	0.000154	0.000538	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NPS—narcolepsy	0.000154	0.000538	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TAC1—narcolepsy	0.000154	0.000538	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000153	0.000534	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HRH3—narcolepsy	0.000151	0.000528	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CPT1B—narcolepsy	0.00015	0.000522	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DQB1—narcolepsy	0.000146	0.000511	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TAC1—narcolepsy	0.000146	0.000511	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NPS—narcolepsy	0.000146	0.000511	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TAC1—narcolepsy	0.000146	0.00051	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NPS—narcolepsy	0.000146	0.00051	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DRB1—narcolepsy	0.000145	0.000505	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HRH3—narcolepsy	0.000141	0.000494	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000141	0.000491	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DQA1—narcolepsy	0.00014	0.000487	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TRH—narcolepsy	0.000139	0.000486	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TNF—narcolepsy	0.000133	0.000464	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CHKB—narcolepsy	0.000133	0.000463	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NPS—narcolepsy	0.000132	0.000459	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TAC1—narcolepsy	0.000132	0.000459	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DRB1—narcolepsy	0.000131	0.000456	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DRB1—narcolepsy	0.000131	0.000456	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DQB1—narcolepsy	0.000131	0.000456	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CPT1B—narcolepsy	0.00013	0.000452	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	0.000128	0.000446	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TAC1—narcolepsy	0.000125	0.000438	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NPS—narcolepsy	0.000125	0.000438	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DRB1—narcolepsy	0.000124	0.000433	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DRB1—narcolepsy	0.000124	0.000431	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—HTR2A—narcolepsy	0.000123	0.000429	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HRH3—narcolepsy	0.000122	0.000426	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HTR2A—narcolepsy	0.00012	0.000418	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HTR2A—narcolepsy	0.000119	0.000417	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NPS—narcolepsy	0.000117	0.000409	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TAC1—narcolepsy	0.000117	0.000409	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000116	0.000404	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TNF—narcolepsy	0.000114	0.000397	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000113	0.000396	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CPT1B—narcolepsy	0.000113	0.000394	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DRB1—narcolepsy	0.000111	0.000389	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000106	0.000371	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000105	0.000368	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	0.000103	0.00036	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR2A—narcolepsy	0.000103	0.000359	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CHKB—narcolepsy	0.000102	0.000357	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR2A—narcolepsy	0.000102	0.000356	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NPS—narcolepsy	0.000101	0.000353	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TAC1—narcolepsy	0.000101	0.000353	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DRB1—narcolepsy	9.92e-05	0.000346	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR2A—narcolepsy	9.28e-05	0.000324	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR2A—narcolepsy	9.28e-05	0.000324	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	9.2e-05	0.000321	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TNF—narcolepsy	9.12e-05	0.000318	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CPT1B—narcolepsy	9.01e-05	0.000315	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR2A—narcolepsy	8.81e-05	0.000307	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR2A—narcolepsy	8.78e-05	0.000307	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR2A—narcolepsy	7.91e-05	0.000276	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR2A—narcolepsy	7.55e-05	0.000263	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR2A—narcolepsy	7.05e-05	0.000246	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CPT1B—narcolepsy	6.96e-05	0.000243	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR2A—narcolepsy	6.09e-05	0.000213	CbGpPWpGaD
